Epidemiology, Risk Factors, and Outcomes of Infections of Lower Limb MEGAprostheses
Recruiting
Observational Study
Lower Limb Megaprosthetis Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 14 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Retrospective, multicenter, non-profit observational study. The study will include consecutive patients who underwent lower-limb megaprosthesis implantation at the participating Centers between January 1, 2020, and June 30, 2023.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 14 years
* Implantation of a lower-limb megaprosthesis at one of the participating centers between January 1, 2020, and June 30, 2023
* At least 2 years of follow-up after megaprosthesis implantation
* Signed informed consent
Exclusion Criteria:
* None
Contacts